The Lobbying Register, read carefully Epicycle

Returns

Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.

Clear all

Showing returns filed by FTI Consulting .

Filed returns
30
match these filters
Matching filed returns per period 0 2 5 7 10 Sep–Dec 2018: 1 filed returns Sep–Dec 2019: 1 filed returns May–Aug 2020: 1 filed returns Sep–Dec 2020: 5 filed returns Jan–Apr 2021: 2 filed returns May–Aug 2021: 1 filed returns Sep–Dec 2021: 1 filed returns May–Aug 2022: 2 filed returns Sep–Dec 2022: 3 filed returns Jan–Apr 2023: 7 filed returns May–Aug 2023: 1 filed returns Sep–Dec 2023: 1 filed returns Jan–Apr 2024: 1 filed returns Jan–Apr 2025: 1 filed returns May–Aug 2025: 1 filed returns Sep–Dec 2025: 1 filed returns 2021 2023 2024 2025
Filed returns per four-month period Click a column to list its returns.
PeriodRegistrantPolicy areaSubject, as filedOfficials namedLink
Sep–Dec 2025 FTI Consulting Health Minister Site Visit to Jazz Pharmaceuticals Manufacturing Facility in Athlone (Public policy or programme) 3 On lobbying.ie
May–Aug 2025 FTI Consulting Health Minister Site Visit to Jazz Pharmaceuticals facility in Athlone (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2025 FTI Consulting Health Jazz Pharmaceuticals Introductory Outreach (Public policy or programme) 7 On lobbying.ie
Jan–Apr 2024 FTI Consulting Health Invitation to attend rescheduled Jazz Pharmaceutical event to mark 20th anniversary and 10 years in Athlone (Public policy or programme) 16 On lobbying.ie
Sep–Dec 2023 FTI Consulting Health Jazz Pharmaceuticals' invitation to attend event marking its 20th anniversary (Public policy or programme) 19 On lobbying.ie
May–Aug 2023 FTI Consulting Health Medica email regarding diabetic retinopathy national screening service. (Matters involving public funds) 3 On lobbying.ie
Jan–Apr 2023 FTI Consulting Health Jazz Pharmaceuticals requested a meeting to discuss Jazz’s operations in Ireland and regulatory approved cannabis-based medicines. (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2023 FTI Consulting Health Jazz Pharmaceuticals requested a meeting to discuss Jazz’s operations in Ireland and regulatory approved cannabis-based medicines. (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2023 FTI Consulting Health Jazz Pharmaceuticals requested a meeting to discuss Jazz’s operations in Ireland and regulatory approved cannabis-based medicines. (Public policy or programme) 2 On lobbying.ie
Jan–Apr 2023 FTI Consulting Health Jazz Pharmaceuticals requested a meeting to discuss Jazz’s operations in Ireland and regulatory approved cannabis-based medicines. (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2023 FTI Consulting Health Jazz Pharmaceuticals virtual meeting to discuss Jazz’s operations in Ireland and regulatory approved cannabis-based medicines. (Public policy or programme) 2 On lobbying.ie
Jan–Apr 2023 FTI Consulting Health Jazz Pharmaceuticals virtual meeting to discuss Jazz’s operations in Ireland and regulatory approved cannabis-based medicines. (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2023 FTI Consulting Health Jazz Pharmaceuticals contacted members of the Oireachtas requesting an introductory meeting about Jazz’s operations in Ireland and regulatory approved cannabis-based medicines. (Public policy or programme) 4 On lobbying.ie
Sep–Dec 2022 FTI Consulting Health Jazz Pharmaceuticals sent an email to Minister Stephen Donnelly and his advisers regarding the Medical Cannabis Access Programme (MCAP) Review to seek details on the format and timeline of the review and offer a meeting… (Public policy or programme) 3 On lobbying.ie
Sep–Dec 2022 FTI Consulting Health Jazz Pharmaceuticals sent an email to TDs and Senators requesting an introductory meeting about Jazz’s operations in Ireland and regulatory approved cannabis-based medicines. (Public policy or programme) 11 On lobbying.ie
Sep–Dec 2022 FTI Consulting Health Jazz Pharmaceuticals sent a follow up email to Deputy John Lahart regarding an introductory meeting about Jazz’s operations in Ireland and regulatory approved cannabis-based medicines. (Public policy or programme) 1 On lobbying.ie
May–Aug 2022 FTI Consulting Health Jazz Pharmaceuticals held introductory meetings to discuss Jazz’s operations in Ireland and the Company’s approach to cannabinoid science and development of regulatory approved cannabis-based medicines. (Public policy or programme) 3 On lobbying.ie
May–Aug 2022 FTI Consulting Health Jazz Pharmaceuticals reached out to a number of DPO’s requesting an introductory meeting to discuss the Company’s approach to cannabinoid science and development of regulatory approved cannabis-based medicines. (Public policy or programme) 16 On lobbying.ie
Sep–Dec 2021 FTI Consulting Health FTI Consulting sent a copy of a press release, on behalf of Jazz Pharmaceuticals, regarding the public announcement of HSE’s reimbursement of Epidyolex (Public policy or programme) 18 On lobbying.ie
May–Aug 2021 FTI Consulting Health GW Pharmaceuticals sent a letter to An Taoiseach Micheal Martin with an offer to brief him on GW’s approach to developing regulatory approved cannabis-based medicines to patients. (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2021 FTI Consulting Health GW Pharmaceuticals sent a letter in the context of membership of the Oireachtas Health Committee, to request a meeting to discuss cannabinoid science and GW Pharmaceuticals. (Public policy or programme) 9 On lobbying.ie
Jan–Apr 2021 FTI Consulting Health GW Pharmaceuticals met with David Cullinane TD and Colm Burke TD, in the context of their membership of the Oireachtas Health Committee, to discuss cannabinoid science and GW Pharmaceuticals. (Public policy or programme) 2 On lobbying.ie
Sep–Dec 2020 FTI Consulting Health GW Pharmaceuticals sent a letter to An Taoiseach Micheal Martin to request a meeting to discuss cannabinoid science and GW Pharmaceuticals in response to issues raised in the Dáil relating to GW’s Epidyolex. (Public policy or programme) 1 On lobbying.ie
Sep–Dec 2020 FTI Consulting Health GW Pharmaceuticals sent a letter to Minister Stephen Donnelly to request a meeting to discuss cannabinoid science and GW Pharmaceuticals. (Public policy or programme) 1 On lobbying.ie
Sep–Dec 2020 FTI Consulting Health GW Pharmaceuticals sent a letter and follow-up to Minister Frank Feighan to request a meeting to discuss cannabinoid science and GW Pharmaceuticals. (Public policy or programme) 1 On lobbying.ie
Sep–Dec 2020 FTI Consulting Health GW Pharmaceuticals sent a letter to Alan Kelly TD to request a meeting to discuss cannabinoid science and GW Pharmaceuticals. (Public policy or programme) 1 On lobbying.ie
Sep–Dec 2020 FTI Consulting Health GW Pharmaceuticals sent a letter to Minister Eamon Ryan to request a meeting to discuss cannabinoid science and GW Pharmaceuticals. (Public policy or programme) 1 On lobbying.ie
May–Aug 2020 FTI Consulting Health GW Pharmaceuticals sent a letter to Minister Stephen Donnelly and Deputy Minister Frank Feighan to request a meeting to discuss cannabinoid science and GW Pharmaceuticals. (Public policy or programme) 2 On lobbying.ie
Sep–Dec 2019 FTI Consulting Health Letter to Minister Harris to request a meeting to discuss cannabinoid science and GW Pharmaceuticals (Public policy or programme) 1 On lobbying.ie
Sep–Dec 2018 FTI Consulting Health Regulations on plain packaging of tobacco products (Legislation) 1 On lobbying.ie

Policy areas in these returns

Public policy areaFiled returnsShareRelative to the largest
Health 30 100.0%